NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?
Main Authors: | Dhammika Leshan Wannigama, Alain Jacquet |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | International Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220321457 |
Similar Items
-
Intravesical BCG in bladder cancer induces innate immune responses against SARS-CoV-2
by: Renate Pichler, et al.
Published: (2023-07-01) -
The impact of non-synonymous mutations on miRNA binding sites within the SARS-CoV-2 NSP3 and NSP4 genes
by: S. M. Ali Hosseini Rad, et al.
Published: (2023-10-01) -
Trained Immunity, BCG and SARS-CoV-2 General Outline and Possible Management in COVID-19
by: Paweł Zapolnik, et al.
Published: (2023-02-01) -
Hypothetical Immunological and Immunogenetic Model of Heterogenous Effects of BCG Vaccination in SARS-CoV-2 Infections: BCG-induced Trained and Heterologous Immunity
by: Dženan Kovačić, et al.
Published: (2021-12-01) -
Innate immune defence: NOD2 and autophagy in the pathogenesis of Crohn’s disease
by: P Hruz, et al.
Published: (2010-12-01)